| pubmed-article:10075594 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C0008109 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C1709854 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C0022646 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C0450127 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C0178539 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C0035015 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C2745955 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C0676831 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C1882923 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C1548437 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C0041703 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:10075594 | lifeskim:mentions | umls-concept:C0723325 | lld:lifeskim |
| pubmed-article:10075594 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10075594 | pubmed:dateCreated | 1999-3-11 | lld:pubmed |
| pubmed-article:10075594 | pubmed:abstractText | A double-blind, placebo-controlled phase III study was performed to assess whether basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, reduced the incidence of acute rejection episodes in renal allograft recipients. | lld:pubmed |
| pubmed-article:10075594 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10075594 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10075594 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10075594 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10075594 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10075594 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10075594 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10075594 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10075594 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10075594 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10075594 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:10075594 | pubmed:issn | 0041-1337 | lld:pubmed |
| pubmed-article:10075594 | pubmed:author | pubmed-author:HallMM | lld:pubmed |
| pubmed-article:10075594 | pubmed:author | pubmed-author:KahanB DBD | lld:pubmed |
| pubmed-article:10075594 | pubmed:author | pubmed-author:RajagopalanP... | lld:pubmed |
| pubmed-article:10075594 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10075594 | pubmed:day | 27 | lld:pubmed |
| pubmed-article:10075594 | pubmed:volume | 67 | lld:pubmed |
| pubmed-article:10075594 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10075594 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10075594 | pubmed:pagination | 276-84 | lld:pubmed |
| pubmed-article:10075594 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:meshHeading | pubmed-meshheading:10075594... | lld:pubmed |
| pubmed-article:10075594 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10075594 | pubmed:articleTitle | Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group. | lld:pubmed |
| pubmed-article:10075594 | pubmed:affiliation | Division of Immunology and Organ Transplantation, University of Texas Medical School, Houston 77030, USA. | lld:pubmed |
| pubmed-article:10075594 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10075594 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10075594 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10075594 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10075594 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:10075594 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10075594 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10075594 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10075594 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10075594 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10075594 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10075594 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10075594 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10075594 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10075594 | lld:pubmed |
